ChemoCentryx Inc.
This article was originally published in Start Up
Executive Summary
Founded by chemokine pioneer and the discoverer of RANTES, Dr. Thomas Schall, ChemoCentryx is pursuing anti-infective and immunotherapy applications of chemokines and their receptors.